University of Patras
In vivo βιολογική αξιολόγηση σαρτανών σε πειραματικά μοντέλα της υπέρτασης
Abstract
dc:descriptionHypertension is one of the most common diseases that occur in humans. A therapeutic approach for the treatment of hypertension is AT1 Angiotensin II receptor antagonists (Sartans). Angiotensin II is the main factor of the Renin - Angiotensin System and plays a determinant role in the regulation of blood pressure. The transdermal drug delivery method is very popular and is used in various treatments. An antihypertensive patch provides multiple benefits (controlled release of the active ingredient, reduced frequency of administration). Based on the above, the ultimate purpose of this present work was the in vivo biological evaluation of Sartans in an effort for transdermal delivery as an alternative therapy of hypertension.The first part of this effort involves the development and the optimization of analytical methodology using High Performance Liquid Chromatography (HPLC), for the detection and quantification of Sartans (Losartan, Valsartan) and of three new synthesized non-peptide antagonists of AT1 Angiotensin II receptor (BV6Na, V8COOH, V8K). These analytical methodologies were necessary for the in vitro experiments of percutaneous diffusion. Human skin used for the in vitro permeation studies were obtained from abdominal plastic surgery. In order to find an appropriate suspension formulation for each substance various suspensions were examined using a variety of permeation enhancers. Our aim was to quantify precisely the substances that passed through the skin by using HPLC. Comparing the rates of flux of the substances through the skin we concluded that the presence of two or more permeation enhancers leads to better permeation as they act synergistically and enhance the penetration of substances into the skin.The second part contains the in vivo experiments in Wistar rats. Initially, we developed a suitable non-invasive experimental model of hypertension with subcutaneous injections of Angiotensin II in order to evaluate the antihypertensive activity of substances. Specifically, Angiotensin II was subcutaneously injected in 8 Wistar rats at four different concentrations (25 μg / kg bw, 50 μg / kg bw, 75 μg / kg bw and 100 μg / kg bw) and pressor response of animals was recorded. The concentration of 50 μg / kg bw proved to be the correct dose that causes hypertensive response greater than 40% and maintained for at least 10 min. Furthermore, using this experimental model we evaluate the non-peptide antagonists of AT1 Angiotensin II receptor after the subcutaneous and transdermal administration, aiming alternative approaches for the treatment of hypertension. The in vivo results of transdermal administration of Losartan and Valsartan showed satisfactory drug release and prolong antihypertensive activity even after 24 h of administration. The synthesized Sartans (BV6Na, V8COOH, V8K) prevent the hypertensive response at 3, 6 and 8 hours after the subcutaneous administration. Finally, the transdermal administration showed weaker antihypertensive effect due to the low diffusion of these substances through the skin barrier.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Michalatou, Michaila
- Μιχαλάτου, Μιχαήλα
Subjects
dc:subject × 18- Υπέρταση
- Αγγειοτενσίνη II
- Υγρή χρωματογραφία υψηλής απόδοσης
- Αναλυτική μεθοδολογία
- Διαδερμική χορήγηση
- Hypertension
- Angiotensin II
- High performance liquid chromatography
- Analytical methodology
- Transdermal delivery
- Φυσικές Επιστήμες
- Χημεία
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Natural Sciences
- Chemical Sciences
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37926